Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study
Cancer Science, EarlyView.
Source: Cancer Science - Category: Cancer & Oncology Authors: Hiroyuki Ohnuma,
Yasushi Sato,
Naotaka Hayasaka,
Teppei Matsuno,
Chisa Fujita,
Masanori Sato,
Takahiro Osuga,
Masahiro Hirakawa,
Koji Miyanishi,
Tamotsu Sagawa,
Koshi Fujikawa,
Motoh Ohi,
Yutaka Okagawa,
Yasushi Tsuji,
Michiaki Hirayama,
Ta Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Esophagus Cancer | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Science | Study | Taxotere